These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1276000)

  • 1. Pharmacokinetics of pancuronium in patients with normal and impaired renal function.
    McLeod K; Watson MJ; Rawlins MD
    Br J Anaesth; 1976 Apr; 48(4):341-5. PubMed ID: 1276000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1977 Aug; 12(1):23-9. PubMed ID: 332502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Plasma concentrations of pancuronium bromide (pavulon) in patients with normal and impaired renal function.
    McLeod K; Watson MJ; Rawlins MD
    Br J Anaesth; 1975 Aug; 47(8):902-3. PubMed ID: 1201173
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of pancuronium in man: a linear system.
    Duvaldestin P; Demetriou M; D'Hollander A
    Eur J Clin Pharmacol; 1982 Oct; 23(4):369-72. PubMed ID: 7173308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jun; 27(6):291-7. PubMed ID: 677435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancuronium pharmacokinetics in patients with liver cirrhosis.
    Duvaldestin P; Agoston S; Henzel D; Kersten UW; Desmonts JM
    Br J Anaesth; 1978 Nov; 50(11):1131-6. PubMed ID: 718783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacodynamic model for pancuronium.
    Hull CJ; Van Beem HB; McLeod K; Sibbald A; Watson MJ
    Br J Anaesth; 1978 Nov; 50(11):1113-23. PubMed ID: 718781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children.
    Meistelman C; Agoston S; Kersten UW; Saint-Maurice C; Bencini AF; Loose JP
    Anesth Analg; 1986 Dec; 65(12):1319-23. PubMed ID: 2877596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of Org NC 45 in man.
    van der Veen F; Bencini A
    Br J Anaesth; 1980; 52 Suppl 1():37S-41S. PubMed ID: 6107104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancuronium blood level monitoring in patients with tetanus.
    Duvaldestin P; Gibert C; Henzel D; Guy P; Desmonts JM
    Intensive Care Med; 1979 Sep; 5(3):111-4. PubMed ID: 500938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure.
    Aitkenhead AR; Vater M; Achola K; Cooper CM; Smith G
    Br J Anaesth; 1984 Aug; 56(8):813-9. PubMed ID: 6743445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition kinetics of pancuronium bromide in patients with total biliary obstruction.
    Somogyi AA; Shanks CA; Triggs EJ
    Br J Anaesth; 1977 Nov; 49(11):1103-8. PubMed ID: 588390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fazadinium in patients with renal failure.
    Duvaldestin P; Bertrand JC; Concina D; Henzel D; Lareng L; Desmonts JM
    Br J Anaesth; 1979 Oct; 51(10):943-7. PubMed ID: 42420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fazadinium and pancuronium: a pharmacodynamic study.
    Hull CJ; English MJ; Sibbald A
    Br J Anaesth; 1980 Dec; 52(12):1209-21. PubMed ID: 6108777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma binding of pancuronium: effects of age, sex, and disease.
    Wood M; Stone WJ; Wood AJ
    Anesth Analg; 1983 Jan; 62(1):29-32. PubMed ID: 6849508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.